HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

Description

To determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer.

Conditions

Prostate Cancer, Lower Urinary Tract Symptoms

Talk to us

Study Overview

On this page

Study Details

Study overview

To determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer.

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Kansas City

University of Kansas Health System, Kansas City, Kansas, United States, 66160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients must be 18 years of age or older
  • * Patients must have bothersome lower urinary tract symptoms (LUTS), defined by American Urological Association Symptom Score (AUA SS) of greater than or equal to 15 and/or as defined by a post-void residual of greater than or equal to 350mL and/or as defined by catheter dependence
  • * Patients must be diagnosed with prostate cancer by pathological tissue analysis
  • * Patients must have elected for radiation with androgen deprivation therapy as the primary treatment modality for their prostate cancer
  • * Patients who are under 18 years of age are not eligible
  • * Patients who have a diagnosis of bladder cancer are not eligible.
  • * Patients with prior treatment for prostate cancer are not eligible.
  • * Patients with any type of prior prostate surgery (minimally invasive, endoscopic, or otherwise) including prior transurethral resection of the prostate (but excluding prior prostate biopsy) are ineligible.
  • * Patients with known metastatic prostate cancer are ineligible
  • * Patients who are enrolled in other surgical or international trials at the time of this study are not eligible

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

Bristol Whiles, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

2035-01